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In Brief
A fundamental question concerns how stem cells are regulated by nutrition and systemic energy homeostasis. Morrison and colleagues demonstrate that leptin receptor acts within skeletal stem cells in the bone marrow as a sensor of systemic energy homeostasis, promoting adipogenesis and inhibiting osteogenesis in response to diet and adiposity.
INTRODUCTION
Leptin is produced by adipocytes and regulates food intake and energy homeostasis by acting on leptin receptor (LepR)-expressing neurons in the hypothalamus (Friedman and Halaas, 1998) . Leptin also regulates bone formation and bone resorption (Ducy et al., 2000; Elefteriou et al., 2005) . Leptin regulates bone partly by acting through hypothalamic neurons to activate the sympathetic nervous system, which can inhibit osteoblast proliferation (Takeda et al., 2002) . However, analysis of the bone phenotypes in these mice is complicated by the fact that mice with germline mutations in Leptin (ob/ob) or Lepr (db/db) develop severe metabolic phenotypes, including obesity, diabetes (Friedman and Halaas, 1998), muscle hypoplasia (Hamrick et al., 2004) , hypogonadism (Chehab et al., 1996) , and hypercortisolism (Ducy et al., 2000) , factors that can independently influence osteogenesis (Reid, 2004) .
A surprisingly high fraction of systemically administered leptin localizes to, and is retained in, the bone marrow (Ceccarini et al., 2009) . Leptin has been suggested to influence osteogenesis and adipogenesis by acting within the bone marrow to regulate the differentiation of mesenchymal stromal cells (Scheller et al., 2010; Thomas et al., 1999) and to inhibit osteoclast differentiation (Holloway et al., 2002) . However, leptin has been observed to promote osteogenesis by cultured mesenchymal stromal cells in some studies (Thomas et al., 1999) and to inhibit osteogenesis in other studies (Scheller et al., 2010) . Leptin has been suggested to inhibit adipogenesis by cultured mesenchymal stromal cells (Ambati et al., 2010; Thomas et al., 1999) . Conditional deletion of Lepr from mesenchymal stromal cells in mouse bone marrow using Col3.6-Cre significantly increased bone mineral density (Scheller et al., 2010) ; however, Col3.6-Cre also recombined in a subset of hypothalamic neurons and the Col3.6-Cre;Lepr fl/fl mice were obese (Scheller et al., 2011) , raising the question of whether LepR influenced bone mass in this study through central effects on hypothalamic neurons or through peripheral effects on bone marrow stromal cells.
Bone marrow mesenchymal stromal cells include skeletal stem cells (SSCs), which are multipotent progenitors that generate fibroblast colonies (CFU-F) in culture (Bianco and Robey, 2015) . Upon differentiation, CFU-F can generate osteoblasts, adipocytes, and chondrocytes (Bianco and Robey, 2015; Friedenstein et al., 1970) . Adult mouse SSCs are enriched among mouse bone marrow stromal cells that express PDGFRa and CD105, but not hematopoietic or endothelial markers (Chan et al., 2009; Morikawa et al., 2009; Omatsu et al., 2010; Park et al., 2012) . These cells also express LepR: LepR + cells include nearly all of the CFU-F in adult mouse bone marrow (Zhou et al., 2014) . Fate mapping of Lepr-Cre-expressing mesenchymal cells in vivo shows that these cells arise postnatally in the bone marrow and make little or no contribution to bone or cartilage during development (Zhou et al., 2014) . However, they are the major source of bone and adipocytes in adult bone marrow (Mizoguchi et al., 2014; Zhou et al., 2014) as well as growth factors for the maintenance of hematopoietic stem cells (HSCs) Ding et al., 2012; Oguro et al., 2013) . While there is little chondrogenesis in adult mice under normal circumstances (Raghunath et al., 2005) , LepR + cells form cartilage in vivo during fracture repair (Zhou et al., 2014) . Prx1-Cre recombines in LepR + stromal cells as well as LepR-negative osteoblasts and chondrocytes within the bone marrow of limb bones, but not in the axial skeleton Greenbaum et al., 2013; Logan et al., 2002) .
We tested whether SSCs in adult mouse bone marrow are regulated by LepR by conditionally deleting Lepr using Prx1-Cre. We found that leptin acts on mesenchymal stromal cells in adult bone marrow to promote adipogenesis at the expense of osteogenesis, rendering these processes responsive to dietary intake. Figure 1A ), and 0.30% ± 0.12%, when identified based on recombination of a conditional reporter, in 10-week-old Prx1-Cre;tdTomato mice ( Figure 1B ). Prx1-Cre recombined in 87% ± 4.9% of the LepR
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À bone marrow stromal cells identified based on antibody staining ( Figure 1A ), but it exhibited little or no recombination in hematopoietic cells ( Figure 1B ). Of the tdTomato + cells, 89% ± 0.92% stained positively for an antibody against LepR at 10 weeks of age by flow cytometry ( Figure 1B ). Confocal analysis showed that most LepR + bone marrow cells from the long bones of Prx1-Cre;tdTomato mice were tdTomato + and vice versa ( Figure 1C ). We conditionally deleted Lepr from bone marrow SSCs by generating Prx1-Cre;Lepr fl/fl mice. The loxp sites in the Lepr fl allele surround the second exon, which contains the start codon used by all known Lepr isoforms (Cohen et al., 2001 ). This would be predicted to cause a loss of function in all Lepr isoforms. The anti-LepR antibody did not effectively stain LepR in thin sections for unknown reasons (data not shown), but it did appear to specifically stain LepR + cells by flow cytometry ( Figure 1E ) and in thick specimens stained in whole mount (Acar et al., 2015; Figure 1F Figure 1D ). In the hypothalamus and brainstem raphe nuclei of Prx1-Cre;tdTomato mice, Prx1-Cre recombined in some perivascular stromal cells, but not in neurons ( Figure S1A ). Consistent with this, Prx1-Cre;Lepr fl/fl mice had normal body mass and normal food intake at 10 weeks and 6 months of age (Figures 1G and 1H) . Plasma chemistry analysis showed normal triglyceride and cholesterol levels (Figures S1B and S1C), as well as normal liver and kidney functions ( Figures S1D and S1E ). There was a mild but statistically significant reduction in blood glucose levels in 10-week-old and 6-month-old Prx1-Cre;Lepr fl/fl mice under free-fed conditions ( Figure 1I ), but we did not observe an increase in plasma leptin or insulin levels ( Figures 1J and 1K ). Prx1-Cre;Lepr fl/fl mice at 10 weeks old showed modestly reduced insulin ( Figure 1K ) and modestly increased glucose tolerance ( Figure 1L ) but normal insulin tolerance relative to control mice (Figures 1M). Prx1-Cre;Lepr fl/fl mice at 6 months old showed normal plasma insulin levels ( Figure 1K ), normal glucose tolerance, and normal insulin tolerance ( Figures 1N and 1O ). Blood cell counts (Figures S1F-S1H) and bone marrow and spleen cellularity ( Figure S1I) 
CD31
À SSCs (n = 3 mice, total, from three independent experiments).
(C) Co-localization of antibody staining for LepR and tdTomato in femurs of Prx1-Cre;tdTomato mice is shown (n = 3 mice from three independent experiments). (G) Body masses of 10-week-old and 6-month-old mice are shown (n = 7-11 mice per genotype, total, from seven independent experiments).
(H) Daily food intake of 10-week-old and 6-month-old mice after 24 hr of fasting is shown (n = 10-12 mice per genotype, total, from six independent experiments).
(I-K) Blood glucose (I), plasma leptin (J), and insulin (K) levels of 10-week-old and 6-month-old mice under free-fed conditions are shown (n = 8-10 mice per genotype, total, from six independent experiments). The statistical significance of differences between treatments in (D)-(M) were assessed using two-tailed Student's paired t tests.
(L-O) Glucose tolerance (L and N) and insulin tolerance (M and O) in 10-week-old and 6-month-old mice after 4 hr of fasting are shown (n = 6-10 mice per genotype, total, from four independent experiments).
The statistical significance of differences between treatments was assessed using repeated-measures two-way ANOVAs with Sidak's multiple comparisons tests (*p < 0.05 and ***p < 0.001). All data represent mean ± SD. See also Figure S1 .
LepR Inhibits Osteogenesis and Promotes Adipogenesis
In Vivo CFU-F frequency was modestly but significantly increased among enzymatically digested bone marrow cells from 6-month-old (K-M) Representative calcein double-labeling images (K) with quantifications of the trabecular bone mineral apposition (L) and trabecular bone formation (M) rates in the femur metaphysis are shown (n = 9 mice per genotype, total, from six independent experiments).
(N) Bone resorption rate analysis was based on the deoxypyridinoline/creatinine ratio in the urine (n = 8 mice per genotype, total, from six independent experiments).
(O and P) Representative perilipin and osteopontin (OPN) staining in femur sections (O) and quantification of the adipocyte number per millimeter 2 (P) are shown (n = 8 mice per genotype, total, from six independent experiments). The statistical significance of difference was assessed using two-tailed Student's paired t test (*p < 0.05, **p < 0.01, and ***p < 0.001). See also Figure S2 .
( Figure 2B ). These results may explain why HSC frequency and hematopoiesis were not affected by Lepr deletion: Lepr is not required for the maintenance of undifferentiated mesenchymal progenitors in the bone marrow, and Lepr deletion did not affect the expression of the niche cell factors, Scf and Cxcl12, by stromal cells ( Figures S2A and S2B ).
To assess the effects of Lepr deletion on osteogenesis, we always compared sex-matched littermates within individual experiments, using paired statistical tests to assess the significance of differences across multiple independent experiments. Different sexes were used in different experiments, such that most conclusions were based on analyses of both male and female mice. Micro-computed tomography (microCT) analysis revealed that trabecular bone volume was significantly increased in the femur metaphysis of S2E ), where Prx1-Cre does not recombine (Logan et al., 2002) . In contrast to the effects of LepR on trabecular bone, the femur length ( Figure S2F ) and cortical bone parameters in the femur diaphysis of Prx1-Cre;Lepr fl/fl mice remained normal (Figures S2G-S2L). LepR thus acts locally to negatively regulate trabecular bone formation. Bone remodeling involves both bone formation and bone resorption. Calcein double labeling showed that the mineral apposition rate and the bone formation rate were significantly increased in Prx1-Cre;Lepr fl/fl mice as compared to littermate controls ( Figures 2K-2M ). Measurement of the urinary bone resorption marker deoxypyridinoline indicated that the bone resorption rate was similar in mice of both genotypes ( Figure 2N ). Consistent with these observations, histomorphometry analysis showed increased numbers of osteoblasts ( Figure S2M ) but normal numbers of osteoclasts in the femur metaphysis of Prx1-Cre;Lepr fl/fl mice ( Figure S2N ). Whole bone marrow cells from Prx1-Cre;Lepr fl/fl mice and littermate controls also gave rise to similar numbers of osteoclasts in culture ( Figure S2O ). Conditional Lepr deletion thus increased bone formation, but we did not detect any effect on bone resorption.
We found significantly decreased numbers of bone marrow adipocytes in Prx1-Cre;Lepr fl/fl mice as compared to littermate controls ( Figures 2O and 2P ). Prx1-Cre alone did not affect the number of adipocytes in the bone marrow as compared to wild-type littermates ( Figure S2P ). Prx1-Cre is also expressed in the adipocyte lineage of inguinal fat depots (Krueger et al., 2014; Sanchez-Gurmaches et al., 2015) . However, Prx1-Cre; Lepr fl/fl mice had normal inguinal and gonadal fat mass (Figure S2Q) , as well as normal leptin expression in both adipose depots ( Figure S2R ). Conditional Lepr deletion thus decreased bone marrow adipogenesis while it increased trabecular bone formation.
LepR Acts in SSCs to Promote Adipogenesis and Inhibit Osteogenesis
Lepr is not expressed by osteoblasts or adipocytes in the bone marrow (Zhou et al., 2014) . However, since Prx1-Cre recombines in both SSCs and osteoblasts, we asked whether deletion of Lepr from mature osteoblasts could influence osteogenesis or adipogenesis. To test this we used Col2.3-Cre, which recombines efficiently in fetal and adult osteoblasts (Liu et al., 2004) . Col2.3-Cre;Lepr fl/fl mice had normal CFU-F frequency ( Figure 3A) and normal BrdU incorporation into PDGFRa + CD45 Figure 3B ). MicroCT analysis showed normal trabecular bone parameters in the femur metaphysis ( Figures 3C-3J ), normal femur length ( Figure S3A) Figure S3L ) or the average number of cells per colony ( Figure S3M ). However, the addition of leptin to wild-type, but not Lepr-deficient, cultures significantly increased the percentage of colonies that contained adipocytes ( Figure 3Q ) and the percentage of colonies that contained only adipocytes ( Figure S3N ), as well as the number of adipocytes per colony ( Figure 3R ). The addition of leptin to wildtype, but not Lepr-deficient, cultures significantly reduced the percentage of colonies that contained osteoblasts ( Figure 3S ) and the percentage of colonies that contained only osteoblasts ( Figure S3O ), as well as the number of osteoblasts per colony ( Figures 3T and S3P) . The effects on osteoblast differentiation were confirmed by qPCR analysis of Osteocalcin expression ( Figure S3Q ). The addition of leptin to the cultures did not significantly affect the proliferation rate of adipocytes or osteoblasts ( Figures S3R and S3S ) or the percentage of adipocytes or osteoblasts that underwent cell death (caspase 3/7 + ; Figures S3T  and S3U ). Therefore, leptin appears to act on undifferentiated mesenchymal stromal cells to promote adipogenesis at the expense of osteogenesis.
LepR Acts Locally to Mediate Diet-Induced Adipogenesis and Bone Loss in Bone Marrow
To test whether LepR regulates SSC function in vivo, we fed control mice or Prx1-Cre;Lepr fl/fl mice with a high-fat diet (HFD) to induce obesity. After 3 months, the body mass of the mice that received the HFD (60% kcal fat) was approximately twice that of mice that received a low-fat diet (LFD, 10% kcal fat; Figure 4A ), irrespective of genotype. The plasma leptin level was dramatically higher in mice that received the HFD, irrespective of genotype ( Figure 4B ). The percentage of femur bone marrow cells that formed CFU-F in culture was significantly lower in wild-type mice (legend continued on next page)
on an HFD as compared to an LFD, but this difference was not observed among Prx1-Cre;Lepr fl/fl mice on different diets (Figure 4C ). This observation is consistent with the data above suggesting that sustained increases in leptin may promote adipocyte differentiation by SSCs.
MicroCT analysis showed that the femur trabecular bone volume was significantly lower in wild-type mice on an HFD as compared to an LFD (Figures 4D-4I) . Among mice fed an HFD, Prx1-Cre;Lepr fl/fl mice had significantly greater femur trabecular bone volume as compared to wild-type mice ( Figures 4D-4I ). These data indicate that HFD feeding significantly reduces femur trabecular bone volume and the effect is at least partially mediated by LepR signaling. Consistent with previous findings (Cao et al., 2009 ), we found no significant effect of HFD feeding on femur mid-diaphysis cortical bone parameters or femur length in either wild-type or Prx1-Cre;Lepr fl/fl mice ( Figures S4A-S4G ).
In addition to the local LepR-mediated effect of HFD feeding on trabecular bone in the femur, there was a more modest systemic effect that was evident in the vertebrae. We observed no significant differences between wild-type and Prx1-Cre;Lepr fl/fl mice in vertebrae ( Figures S4H-S4M) , where Prx1-Cre does not recombine (Logan et al., 2002) . However, HFD feeding modestly but significantly reduced bone volume in the femurs ( Figure 4D ) and vertebrae ( Figures S4H and S4I ) of both wildtype and Prx1-Cre;Lepr fl/fl mice, without significantly affecting trabecular number, trabecular thickness, trabecular spacing, or bone mineral density of the vertebrae (Figures S4J-S4M ). This modest systemic effect also may explain why HFD feeding significantly decreased femur trabecular bone volume in Prx1-Cre;Lepr fl/fl mice ( Figures 4D-4I ). Taken together, our data indicate there are both local and systemic effects of HFD feeding on osteogenesis. The local LepR-mediated effect of HFD feeding on femur trabecular bone appeared to be explained by changes in the rate of bone formation. Calcein double labeling showed that HFD feeding significantly reduced the mineral apposition and bone formation rates in the femur trabecular bone of wild-type mice, but not in Prx1-Cre;Lepr fl/fl mice ( Figures 4J and 4K ). The trabecular bone mineral apposition and bone formation rates were both significantly higher in Prx1-Cre;Lepr fl/fl as compared to control mice, irrespective of whether they were fed with an HFD or an LFD ( Figures 4J and 4K ). In the femur, HFD thus significantly reduced trabecular bone formation, while Lepr deletion significantly increased trabecular bone formation, suggesting that diet-induced leptin acts locally in the bone marrow to negatively regulate trabecular bone formation by SSCs.
The modest systemic effect of HFD feeding on bone appeared to be explained largely by increased bone resorption. Consistent with a prior study (Kyung et al., 2009) , we found that the bone resorption rate and the number of osteoclasts in the distal femur metaphysis were significantly increased in both control mice and Prx1-Cre;Lepr fl/fl mice fed an HFD, but they did not significantly differ between the control and Prx1-Cre;Lepr fl/fl mice ( Figures 4L  and S4N ). This increased bone resorption rate might contribute to the decreased trabecular bone volume in the femur metaphysis of mice on an HFD ( Figure 4D ), as well as the decrease in vertebral bone volume after HFD feeding ( Figure S4I) .
In contrast to the decrease in bone volume after HFD feeding, we found significantly increased numbers of adipocytes in the femur bone marrow of control, but not Prx1-Cre;Lepr fl/fl , mice after HFD feeding ( Figures 4M and 4N) . Irrespective of diet, the femur bone marrow of Prx1-Cre;Lepr fl/fl mice had significantly fewer adipocytes than control bone marrow ( Figures 4M and 4N ).
Our results suggest that diet-induced leptin acts on SSCs, and perhaps other mesenchymal stromal cells, to promote adipogenesis at the expense of osteogenesis in the bone marrow. In contrast to femoral bone marrow, we observed only rare adipocytes in vertebral bone marrow and did not detect any increase in adipocytes after HFD feeding ( Figure S4O ). SSCs in different bones thus exhibit differences in the extent to which they engage in adipogenesis in response to dietary change. 
LepR Negatively Regulates Bone Regeneration after Injury
CD31
À SSCs were sorted at clonal density to form CFU-F for 8 days, followed by adipogenic or osteogenic differentiation for 4 or 7 days, respectively. Half of the cultures were supplemented with 1 mg/ml recombinant leptin throughout the experiment. The frequency of adipocytecontaining colonies (Q) and the average number of adipocytes per colony (R) were quantified by Oil Red O staining. The frequency of osteoblast-containing colonies (S) and the average number of osteoblasts per colony (T) were quantified by alkaline phosphatase staining (n = 3 independent experiments).
The statistical significance of differences was assessed using two-way ANOVAs with Sidak's multiple comparisons tests (**p < 0.01 and ***p < 0.001). See also Figure S3 . (L) Bone resorption rate was based on the deoxypyridinoline/creatinine ratio in the urine (n = 8 mice per genotype, total, from eight independent experiments).
(legend continued on next page)
callus bone content at the fracture site was higher in Prx1-Cre; Lepr fl/fl as compared to control mice ( Figure 5C ), while the callus cartilage content was much lower in Prx1-Cre;Lepr fl/fl mice (Figure 5D ). Two weeks after bone fracture, microCT analysis showed significantly increased trabecular bone volume in the callus of Prx1-Cre;Lepr fl/fl as compared to control mice (Figures 5E and 5G) . This was associated with significantly increased trabecular number ( Figure 5H ) and trabecular thickness ( , and trabecular spacing (J) 2 weeks after bone fracture are shown (n = 3-6 mice per genotype, total, from three independent experiments). The statistical significance of differences was assessed using two-tailed Student's t tests (*p < 0.05 and **p < 0.01).
that leptin negatively regulates fracture healing by inhibiting osteogenesis in the femoral bone marrow. Sublethal irradiation causes LepR + SSCs to go into cycle to generate increased numbers of osteoblasts and adipocytes in the bone marrow (Zhou et al., 2014) . We thus tested whether LepR regulates bone regeneration after irradiation. Prx1-Cre; Lepr fl/fl mice and controls exhibited similar kinetics with respect to recovery of blood cell counts after irradiation ( Figures S5A-S5H ). Eight weeks after irradiation, the femur trabecular bone volume was significantly increased in Prx1-Cre;Lepr fl/fl as compared to control mice after irradiation ( Figures 6C-6J ). Femur cortical bone parameters ( Figures S5K-S5P ) and vertebral bone parameters ( Figures S5Q-S5S ) were similar in Prx1-Cre; Lepr fl/fl and control mice. These results indicate that LepR negatively regulates osteogenesis after irradiation.
Eight weeks after irradiation, femoral bone marrow showed a dramatic increase in the number of adipocytes as compared to non-irradiated mice (compare Figure 6A to Figure 4M ), but there was no difference in the number of adipocytes in Prx1-Cre; Lepr fl/fl versus control mice ( Figures 6A and 6B ). Vertebral bone marrow also exhibited a dramatic increase in the number of adipocytes in both Prx1-Cre;Lepr fl/fl and control mice ( Figures   S5I and S5J , compare to Figure S4O ). While LepR is required for increased bone marrow adipogenesis in response to an HFD, it is not required for adipogenesis in response to irradiation. The statistical significance of difference was assessed using two-tailed Student's paired t test (*p < 0.05 and **p < 0.01). See also Figure S5 . (legend continued on next page) Ghilardi and Skoda, 1997; Vaisse et al., 1996) . Consistent with this, we observed a dramatic reduction in phospho-Stat3 (Tyr705) levels in Prx1-Cre;Lepr fl/fl as compared to control Figure 7A ). In contrast,
we observed similar levels of phospho-Akt (473) Figure S6A ). To test whether Stat3 mediates the effects of LepR signaling on SSCs, we administered leptin along with a Stat3 inhibitor, STA-21 (Song et al., 2005) , to cultured bone marrow mesenchymal stromal cells. STA-21 blocked the effects of leptin on adipogenic ( Figure 7B ) and osteogenic differentiation in culture (Figures 7C, S6B, and S6C) .
To test whether Jak2 activation promotes adipogenesis and inhibits osteogenesis in vivo, we generated Prx1-Cre;Jak2 V617F mice, in which Jak2 was constitutively activated in mesenchymal cells within limb bones. These mice had significantly fewer CFU-F in their femurs as compared to littermate controls (Figure 7D) . There was also a modest but significant reduction of femur length in Prx1-Cre;Jak2 V617F mice ( Figure 7E ). Femurs from Prx1-Cre;Jak2 V617F mice exhibited significantly reduced trabecular bone volume as compared to femurs from controls ( Figures  7F-7L ). Femur cortical bone parameters ( Figures S6D-S6I ) and vertebral bone parameters ( Figures S6J-S6L ) were similar in Prx1-Cre;Jak2 V617F and control mice. Conversely, the number of bone marrow adipocytes significantly increased in Prx1-Cre; Jak2 V617F as compared to control femurs ( Figures 7M and 7N ). Constitutive Jak2 activation, like LepR activation, thus promotes adipogenesis and reduces osteogenesis in the bone marrow.
Our qRT-PCR analysis of uncultured PDGFRa + CD45
À cells from Prx1-Cre;Lepr fl/fl and control mice showed that the expression of Cebpa, a key transcription factor that promotes adipogenesis (Richard and Stephens, 2011) , was significantly reduced in Prx1-Cre;Lepr fl/fl SSCs ( Figure 7O ). In contrast, the expression of Wnt4, a non-canonical Wnt ligand that promotes osteogenesis (Chang et al., 2007) , was significantly increased in Prx1-Cre;Lepr fl/fl SSCs ( Figure 7O ). Socs3, a downstream target of Stat3 and a negative regulator of osteogenesis (Matsushita et al., 2014) , also was significantly reduced in expression in Prx1-Cre;Lepr fl/fl SSCs ( Figure 7O Figure S6M ). These data suggest that LepR signaling promotes adipogenesis at the expense of osteogenesis in bone marrow mesenchymal stromal cells by activating Jak2/Stat3 signaling, which promotes Cebpa transcription and negatively regulates Wnt4 transcription.
DISCUSSION
A number of studies have shown that stem/progenitor cells in the intestine (O'Brien et al., 2011; Yilmaz et al., 2012) , adipose depots (Jeffery et al., 2015) , and germline (Drummond-Barbosa and Spradling, 2001 ) are regulated by organismal nutritional status. Diet has long been known to influence adipogenesis and osteogenesis through a variety of systemic mechanisms.
Here we showed that mesenchymal stromal cells in the adult bone marrow also are regulated by nutritional status as a consequence of local leptin/LepR signaling. An HFD increased leptin expression ( Figure 4B ), promoting adipogenesis and inhibiting osteogenesis in the bone marrow ( Figures 4E and 4N ). Conditional deletion of Lepr from bone marrow SSCs did not cause obesity or type II diabetes-associated hyperglycemia (as observed in ob/ob and db/db mice), but it modestly increased glucose tolerance. This could potentially reflect increased bone formation and glucose uptake by osteoblasts (Wei et al., 2015) or increased leptin sensitivity after deleting bone marrow LepR that may sequester leptin in the bone marrow (Ceccarini et al., 2009) .
A recent study showed that Gremlin-1-CreER-expressing cells from the metaphysis of long bones give rise to osteoblasts, chondrocytes, and stromal cells in postnatal bone marrow (Worthley et al., 2015) . The level at which Gremlin-CreER-expressing cells contribute to these cell populations is unclear, though Worthley et al. (2015) indicated that the contribution appears to decline with time in adult mice. The relationship between these cells and the LepR + cells in the bone marrow, which give rise to osteoblasts and adipocytes primarily after 2 months of age, has not yet been tested. LepR + cells express Gremlin-1 (data not shown) but exhibit little contribution to chondrocytes, except in the context of fracture healing. The two cell populations could thus be lineally, temporally, and/or spatially distinct. Nonetheless, our current data raise the question of whether the Gremlin-1-expressing cells also might be regulated by leptin.
The reciprocal negative effects of adipogenesis on osteogenesis have long been recognized (Fazeli et al., 2013; Rosen and Bouxsein, 2006; Sadie-Van Gijsen et al., 2013) , but the underlying molecular mechanisms are complex. Our observation that LepR mediates diet-induced fat accumulation in the bone marrow and inhibits osteogenesis by SSCs is particularly interesting given that clinical evidence indicates that fat mass negatively correlates with bone mass when the mechanical loading effects of the total body weight are controlled for (Hsu et al., 2006; Zhao et al., 2007) . We also found that LepR negatively regulates bone regeneration (Figures 5 and 6 ), which is consistent Statistical significance was assessed using one-way ANOVAs with Sidak's multiple comparisons tests (B and C) or two-tailed Student's paired t tests (D-O) (*p < 0.05, **p < 0.01, and ***p < 0.001).
See also Figure S6 .
with the observation that HFD-induced obesity delays fracture healing (Brown et al., 2014) and that aberrant marrow adiposity is associated with skeletal deficits in patients after irradiation (Mostoufi-Moab et al., 2015) . LepR is thus a nutritional/adiposity sensor that acts on mesenchymal stromal cells in the bone marrow to promote adipogenesis and inhibit osteogenesis, implicating peripheral LepR antagonism as a potential strategy to treat osteoporosis.
EXPERIMENTAL PROCEDURES Mice
Mice used in this study included Lepr fl/fl mice (Cohen et al., 2001 ), Prx1-Cre mice (Logan et al., 2002) , loxp-tdTomato mice (Madisen et al., 2010) , Col2.3-Cre mice (Liu et al., 2004) , and Jak2 V617F mice (Hasan et al., 2013) . For HFD feeding experiments, 2-to 3-month-old mice were fed with control LFD (D12450B, Research Diets) or HFD (D12492, Research Diets) for 3 months with body weight monitored every week. All mice were backcrossed at least six times onto a C57BL/6 background and housed in the Animal Resource Center at the University of Texas Southwestern Medical Center (UTSW). All procedures were approved by the UTSW Institutional Animal Care and Use Committee.
MicroCT Analysis
Femurs and lumbar vertebrae were dissected, fixed overnight in 4% paraformaldehyde, and stored in 70% ethanol at 4 C. The femurs and vertebrae were scanned at the isotropic voxel sizes of 3.5 and 7 mm, respectively, at the Texas A&M University Baylor College of Dentistry (MicroCT 35; Scanco Medical). Trabecular bone parameters were measured in the distal metaphysis of the femurs. We started analyzing slices at the bottom of the distal growth plate, where the epiphyseal cap structure completely disappeared, and continued for 200 slices (3.5 mm/slice) toward the proximal end of the femur. Cortical bone parameters were measured by analyzing 100 slices in middiaphysis femurs. Vertebral bone parameters were measured by analyzing 200 slices in L3 lumbar vertebrae.
Statistical Analysis
The statistical significance of differences between two groups was assessed using two-tailed Student's t tests. The statistical significance of differences among more than two groups was assessed using one-way ANOVAs with Sidak's multiple comparison tests. The statistical significance of differences between treatments in the HFD feeding experiments, ex vivo SSC differentiation experiments, glucose and insulin tolerance tests, long-term competitive reconstitution assays, and hematopoietic recovery analysis were assessed using two-way ANOVAs with Bonferroni's or Sidak's multiple comparison tests. All data represent mean ± SD (*p < 0.05, **p < 0.01, and ***p < 0.001). See the Supplemental Experimental Procedures for additional methods. 
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